Video of the week: Red Lab Coat Day 2018 - Kiss Goodbye to MS

 

Every year on 1 May 1 research groups throughout Australia participate in Red Lab Coat Day. The day aims to raise the profile of and funding for research on multiple sclerosis organized.

 

This year your CCS Neuroscience MS researchers have put together a hilarious video for the 'Kiss Goodbye to MS' campaign to raise awareness and funds. The video is part of the 'Battle of the Labs', and Helmut Butzkueven, Vilija Jokabaitis, Mastura Monif, Steven Petratos and Anneke van der Walt would love you to vote for it. They want to win the surprise prize!

 

Vote here: https://kissgoodbyetoms.org/red-lab-coat-day-2018/

Please share the link with all your family, friends and colleagues, ask them to ‘kiss’ (vote) for their favourite and post on your social media using the attached social tiles and the #KissGoodbyeToMS and #RedLabCoatDay hashtags.

 

See the video and the photo gallery here:

 

View CCS video: https://youtu.be/1Ezbx5CKjSA

Gallery: https://photos.app.goo.gl/on1sYn1XmtXp1jlD3

 

What's on at CCS 07-11 May 2018

PhD student Liriye Kurtovic pre-
senting at the 2016 CCS 3MT heat.
Liriye is presenting on Tues 8 May

Central Clinical School (CCS) has regular seminar series and postgraduate presentations. Event notices are posted on the CCS Events calendar.

CCS staff and students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the CCS intranet's Announcements page.

See CCS seminar index:  https://www.monash.edu/medicine/ccs/headlines/events-calendar

What's on at CCS 07-11 May 2018

Mon	07/05/2018	►	11:00	PhD Pre-submission seminar: Mr Kristopher Nilsen
Tue	08/05/2018	►	14:00	PhD Pre-Submission Milestone: Ms Liriye Kurtovic
Wed	09/05/2018	►	11:30	Seminar: Dr Evelyn Tsantikos
Thur	10/05/2018	►	11:30	Cutting Edge Journal Club: Dr Dimitra Zotos
		►	12:00	Alfred Grand Rounds

Invitation to 14 June 2018 Jeffrey Modell Immunodeficiencies launch

You are invited to the JMF Centre for Primary Immunodeficiencies Melbourne Opening Symposium.

Invitation link
https://jmfmelbournelaunch.eventbrite.com.au and input code: JMF18

Recent CCS publications: 28 April – 4 May 2018

Professor Helmut Butzkueven and Dr Vilija
Jokubaitis are co-authors on a recent paper
investigating genetic determinants of the rate
of disability progression in multiple sclerosis

Recent publications for Central Clinical School affiliated authors in the following departments. Note, browse down this entry for complete publications list. Linked headings for each section are to the departments' home pages.

Diabetes

Immunology

Infectious Diseases

Neuroscience

Surgery 

Monash findings offer hope for new lung disease drug

Associate Professor Margaret Hibbs' group. There are a number
of co-authors on the paper which has identified a protein important
for controlling emphysema. L-R: Dr Evelyn Tsantikos, Ms Cassandra
Castelino, Ms April Raftery, Associate Professor Margaret Hibbs,
Mr Tim Gottschalk, Ms Lakshanie Wickramasinghe, Dr Maverick
Lau, Dr Jess Borger

by Anne Crawford

Monash University researchers have identified a critical role for a protein known as G-CSF in chronic obstructive pulmonary disease (COPD), an incurable lung disease often referred to as emphysema.

COPD is the third most common cause of death worldwide, afflicting 29% of people over 75 in Australia and its incidence is increasing. It responds poorly to current therapies, which have remained largely unchanged for decades.

The multi-disciplinary research team, led by Associate Professor Margaret Hibbs from the Department of Immunology and Pathology, showed that lung disease and other disease comorbidities such as osteoporosis, heart disease and body wasting failed to develop in an experimental COPD model when G-CSF was “knocked out” genetically. They also demonstrated that G-CSF levels were elevated in the lungs of patients with COPD, suggesting it played a destructive role.

Participants sought: Effects of dietary resistant starch on serum acetate levels

The study

Investigating the dose response effects on palatability, tolerability and serum acetate levels of acetylated high-amylose maize starch (HAMSA) in healthy adults.

What is the hypothesis?

Resistant starches such as high amylose maize starch (HAMS) reach the large intestine undigested and are later fermented by the gut microbiota, producing short-chain fatty acids, one of which is acetate. Elevated serum acetate levels are thought to confer health benefits through immune and blood sugar modulation. So far, vinegars have been used to investigate physiological effects of oral ingestion of acetate.

Position vacant: Research Scientist

Miss Heather Cleland (left) and Dr Shiva Akbarzadeh
(right) work on skin tissue engineering. See more about
the Skin Bioengineering research group

Wanted! A research scientist to join a small and active group of scientists committed to translational research in skin tissue engineering at The Victorian Adult Burns Service, The Alfred, collaborating with Monash University scientists in the field. To be successful for this role you will need to have a PhD in cell biology or equivalent and proven experience in primary cell culture and cell biology techniques. Experience in skin biology, wound healing, platelet biology and mouse models are highly desirable. You will require to work independently and in a team and have a proven track record in producing high quality research outcomes and manuscript preparation.

https://careers.alfredhealth.org.au/job/12422/4XONA904S/research-scientist